Envista Corp (NVST)

The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.

Stocks like FHI, NVST, COMM and FLS are seeing price strength and have a high chance of carrying the momentum forward.

Envista (NVST) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Four GARP picks with low PEG ratios and strong growth potential include Kontoor Brands, Envista, Western Digital and LATAM Airlines.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck ...

Envista Q2 Revenue Jumps 7.7%

ARMN, QUAD, NVST, INDV and BJRI have been added to the Zacks Rank #1 (Strong Buy) List on August 5, 2025.

Envista's Q2 results showed broad-based growth, segment recovery, and improved margins, signaling early signs of stabilization and operational turnaround. Spark and implants businesses are rebounding,...

Explore how Envista's (NVST) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.